Hyosung Chemical Corp. (298000) AI Stock Analysis

Top Page

Hyosung Chemical Corp.

(Korea Exchange:298000)

Select Model

Rating:46Neutral

Price Target:$44,737.00▼(-3.79% Downside)

Action:initiatedcoverage

Date:10/28/26

The score is held down primarily by weak financial quality (high leverage and persistently negative free cash flow) and a bearish technical setup (price below key moving averages with negative MACD). A very low P/E provides some valuation support, but it is not enough to offset the balance sheet and cash-flow risk.

Positive Factors

Revenue and Margin ImprovementThe latest period shows a meaningful operating improvement, with revenue growth accompanied by positive gross, EBIT, and EBITDA margins. If this progress persists, it can strengthen internal funding capacity and provide a more durable earnings base across the next several quarters.

Negative Factors

High LeverageDebt remains high relative to equity, leaving the capital structure stretched for a cyclical chemicals business. This leverage can increase refinancing exposure, reduce flexibility during downturns, and constrain the company’s ability to fund growth or absorb weaker operating conditions without additional financial pressure.

Hyosung Chemical Corp. (298000) vs. SPDR S&P 500 ETF (SPY)

Market Cap: KRW 175.20B
Dividend Yield: ―
Average Volume (3M): 37.01K
Price to Earnings (P/E): 0.3
Beta (1Y): 0.70
Revenue Growth: 14.27%
EPS Growth: -102.83%
Country: KR
Employees: 884
Sector: General
Sector Strength: 55
Industry: Chemicals

Hyosung Chemical Corp. Business Overview & Revenue Model

Company Description

Based in Seoul, South Korea, Hyosung Chemical Corporation manufactures and distributes a diverse array of chemical solutions across both domestic and global markets. The company supplies various grades of polypropylene (PP) under its TOPILENE brand,...

Hyosung Chemical Corp. Financial Statement Overview

Summary

Income statement is improving (TTM revenue +10.8% with margins turning positive), but overall fundamentals are constrained by a highly leveraged balance sheet (debt-to-equity ~2.19; recently thin/negative equity history) and very weak cash generation (TTM operating cash flow near breakeven while free cash flow is deeply negative). These factors materially limit durability and financial flexibility despite the near-term turnaround.

Income Statement

58Neutral

Balance Sheet

35Negative

Cash Flow

22Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.61T	2.34T	2.84T	2.79T	2.88T	2.45T
Gross Profit	156.33B	-70.50B	-77.00B	-82.05B	-230.16B	249.27B
EBITDA	174.34B	-45.66B	37.71B	49.81B	-59.27B	329.18B
Net Income	543.00B	393.10B	-325.72B	-346.91B	-408.87B	58.42B
Balance Sheet
Total Assets	2.96T	2.59T	3.27T	3.12T	3.13T	3.06T
Cash, Cash Equivalents and Short-Term Investments	98.60B	85.26B	62.81B	54.10B	107.08B	35.51B
Total Debt	1.54T	1.61T	2.73T	2.04T	2.56T	2.03T
Total Liabilities	1.95T	1.96T	3.34T	3.05T	3.02T	2.55T
Stockholders Equity	703.39B	369.29B	-67.99B	61.88B	114.62B	501.45B
Cash Flow
Free Cash Flow	-131.34B	-129.03B	-230.47B	-67.51B	-378.88B	-273.01B
Operating Cash Flow	241.25M	-85.02B	-83.89B	75.34B	-134.76B	68.67B
Investing Cash Flow	-38.95B	874.81B	-165.49B	-151.16B	-230.71B	-307.44B
Financing Cash Flow	29.17B	-773.98B	221.26B	30.97B	416.72B	262.69B

Hyosung Chemical Corp. Technical Analysis

Technical Analysis SentimentNegative

Last Price46500.00

Price Trends

50DMA54467.00Negative

100DMA56946.50Negative

200DMA47923.25Negative

Market Momentum

MACD-2472.69Negative

RSI37.18Neutral

STOCH37.35Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:298000, the sentiment is Negative. The current price of 46500.00 is below the 20-day moving average (MA) of 48537.50, below the 50-day MA of 54467.00, and below the 200-day MA of 47923.25, indicating a bearish trend. The MACD of -2472.69 indicates Negative momentum. The RSI at 37.18 is Neutral, neither overbought nor oversold. The STOCH value of 37.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:298000.

Hyosung Chemical Corp. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

KR:298000 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KR:006650	60Neutral	KRW 489.76B	7.76	―	1.64%	11.00%	15.24%
KR:014680	60Neutral	KRW 2.18T	14.97	―	1.23%	14.92%	12.85%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
KR:456040	47Neutral	KRW 501.34B	56.61	―	―	2.23%	―
KR:011170	46Neutral	KRW 1.94T	-1.66	―	2.17%	5.09%	44.43%
KR:298000	46Neutral	KRW 175.20B	0.32	―	―	14.27%	-102.83%
KR:457190	44Neutral	KRW 2.17T	333.96	―	―	14.19%	22.27%

* General Sector Average

Performance Comparison

KR:298000 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
KR:298000	Hyosung Chemical Corp.	46500.00	7600.00	19.54%
KR:006650	Korea Petro Chemical Ind. Co., Ltd.	79300.00	-52009.77	-39.61%
KR:011170	Lotte Chemical Corporation	46100.00	-24375.49	-34.59%
KR:014680	Hansol Chemical Co., Ltd	211500.00	-18860.17	-8.19%
KR:456040	OCI Company Ltd.	56000.00	-6200.00	-9.97%
KR:457190	ISU SPECIALTY CHEMICAL Co., Ltd.	73100.00	15900.00	27.80%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026

Hyosung Chemical Corp. AI Stock Analysis

Top Page